Multiple Myeloma: Molecular Biology, Diagnosis and Treatment

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Multiple myeloma represents malignant transformation of terminally differentiated plasma cells, and makes up 1% of all cancers and 10% of hematological malignancies with a male predominance and higher incidence in older patients. The disease remains incurable with current treatments and contributes to considerable morbidity and mortality among affected patients. The past decade has seen dramatic progress, both in our understanding of the molecular basis of the disease and in the development of new therapies for the disease. The high response rates seen with the new drugs, especially in combination, has led to a paradigm change in the approach to the patient with myeloma.

Original languageEnglish (US)
Title of host publicationAdvances in Malignant Hematology
PublisherWiley-Blackwell
Pages315-341
Number of pages27
ISBN (Print)9781405196260
DOIs
StatePublished - Mar 24 2011

Keywords

  • Chromosomal translocations
  • Genetics
  • Immunoglobulins
  • Immunomodulatory drugs
  • Monoclonal protein
  • Multiple myeloma
  • Plasma cell
  • Prognosis
  • Proteasome inhibitors
  • Stem cell transplant

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Multiple Myeloma: Molecular Biology, Diagnosis and Treatment'. Together they form a unique fingerprint.

  • Cite this